A Comprehensive Overview of Vitiligo

The depigmenting skin condition known as vitiligo is brought on by a specific melanocyte depletion that weakens the melanin in the skin's afflicted regions. The macule has distinct edges, is chalky-white, non-scaly, and entirely amelanotic [1]. Depigmentation typically manifests symmetrically, starting on your fingers, toes, forearms, elbows, and upper arms and extending to the area around your lips and eyes. It is impossible to understand such symmetry [2]. Hypopigmented patches are the hallmark of the condition and are often initially observed on the knuckles, fingertips, and the region around the eyes, lips, toes, and reproductive organs [3]. Bilateral or generalized vitiligo can start at any age and frequently advances intermittently throughout a person's lifetime [2]. If less than one centimetre of skin is losing colour, the lesion is called a macule; if more, it is called a patch [4]. Both men and women are equally impacted, however a small number of studies have found a female predominance. This may be due to the fact that women are more prone to suffer from autoimmune disorders or to have self-consciousness about their appearance when they seek medical attention [5]. In 1975, Thomas B. Fitzpatrick developed Fitzpatrick skin phototypes, which are based on an individual's skin tone and how they burn and tan when exposed to sunlight [6].  A prospective population-based and case-control research study has most commonly used the Fitzpatrick skin type to examine sun sensitivity and the factors that contribute to skin cancer, such as UV radiation exposure, tanning, and protective behaviours [7]. Prevalence rates vary geographically, with Africa and India often having higher rates. At 9.98%, the Indian subcontinent has the highest frequency of vitiligo [8], followed by Nigeria at 2.8% and Romania at 2.28% [9]. Numerous Indian studies indicate that the prevalence of vitiligo among dermatological outpatients varies from 0.25 to 4%, with the highest frequency occurring in the states of Gujarat and Rajasthan (8.8%) [10]. The distinctive lesion is a chalky-white, nonscaly, completely amelanotic macule with clear borders. The pathophysiology of vitiligo has been better understood in recent years, and it is now categorically categorised as an autoimmune disease linked to environmental and genetic causes as well as well as problems in metabolism, oxidative stress, and cell detachment [11]. Because the disease causes social isolation, stigmatisation, and low self-esteem in those who are affected, it significantly lowers the quality of life for both adults and children [12]. Originating from the Latin term "vitium," which denotes a "blemishing fault," The complex interaction of autoimmune, environmental, and genetic variables is where it started. [13]

Etiology:

The cause of vitiligo is still unknown and the focus of numerous research projects. Since autoantigens recognised by T cells from vitiligo patients have been discovered in recent decades, it is thought to be an autoimmune-related disease. Numerous distinct mechanisms have been implicated in the development of white patches and the death of melanocytes in vitiligo. Neural, genetic, autoimmune, oxidative stress, inflammatory mediator production, and other pathways for melanocyte separation are among them [11].

• Autoimmune theory:

The most popular and well-established theory, known as "autoimmune mediation," postulates that when the response is disrupted, autoimmune effector mechanisms—such as memory cytotoxic T cells or autoantibodies directed against melanocyte. The connection between vitiligo and autoimmune diseases is widely acknowledged [14]. The fact that vitiligo is linked to various autoimmune diseases, that organ-specific antibodies are present in vitiligo patients, and that vitiligo treatments indirectly modulate the immune system all lend credence to the autoimmune idea [15]. The finding that checkpoint inhibitor-treated neoplastic patients may also develop the condition lends further credence to the idea that autoimmunity plays a part in vitiligo development. As a result, it has been noted that in patients with metastatic melanoma receiving treatment with inhibitors of the cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death-1 protein (PD-1) pathways, vitiligo development may also result in improved response and survival rates [16].

• Genetic Theory:

Several candidate genes have been identified as contributing to the polygenic nature of vitiligo, including the major histocompatibility complex (MHC), angiotensin-converting enzyme (ACE), catalase (CAT), cytotoxic T lymphocyte antigen-4 (CTLA-4), protein tyrosine phosphatase, human leukocyte antigen (HLA), and interleukin-2 receptor A (IL2RA). A genetic connection between widespread vitiligo and all of these immune-regulating factors has been investigated [17]. Currently, a number of related genes have been found. Along with other pigmentary, autoimmune, and autoinflammatory illnesses, they play a role in immunological modulation, melanogenesis, and apoptosis. [18] The enzyme tyrosinase, which is encoded by the TYR gene, catalyses the melanin biosynthesis's rate-limiting stages. In generalised vitiligo, tyrosinase is a key autoantigen present [19]. Large protein synthesis during melanin formation raises the possibility that those proteins will misfold, which triggers the unfolded protein response, a stress pathway inside the cell. Vitiligo has been linked to XBP1P1, the gene that codes for X-box binding protein. The 23% concordance rate of monozygotic twins emphasises the significance of extra stochastic or environmental elements in the vitiligo development process [20].

• Oxidative Stress Theory:

As per the oxidative stress theory, the main cause of vitiligo is the intra-epidermal accumulation of reactive oxygen species, the most well-known of which is hydrogen peroxide (H2O2), whose concentration at this concentration, the H2O2 changes the mitochondria, causing the melanocytes to perish by apoptosis. Vitiligo patients usually show alterations in redox status markers. MDA is an indication of oxidative stress and a byproduct of lipid peroxidation. The activity of GPx requires selenium, a vital antioxidant present in erythrocytes. SOD neutralises peroxide radicals, reducing their toxicity, and CAT transforms them into oxygen (O2) and water (H2O). Vitiligo patients exhibit low levels of the enzyme CAT, significantly higher levels of SOD, decreased erythrocyte GPx activity, and low levels of vitamins C and E in their blood and epidermis [21]. Melanocytes react to stress by releasing reactive oxygen species (ROS). The antioxidant system is then widely altered as a result [22]. It has been proposed that the heightened sensitivity of melanocytes to external pro-oxidant stimuli in vitiligo is caused by an imbalance between pro-oxidants and antioxidants [23]. Melanocytes are poisoned by melanin synthesis itself. Melanocytes use energy for a process called melanogenesis, which causes the skin to become pro-oxidant [24].

• Neural Theory:

According to the neural theory, neurochemicals released by nerve endings have the ability to harm melanocytes or decrease the formation of melanin. It also suggests a link between the catalase gene and the pathophysiology of vitiligo. In practically every living organism, the peroxisome enzyme catalase is found. It shields cells against extremely reactive oxygen radicals by promoting the breakdown of hydrogen peroxide into water and oxygen. Patients with vitiligo have reduced catalase enzyme activity in both their lesional and non lesional skin [11].

• Biochemical Theory:

The accumulation of harmful intermediate metabolites of melanin formation and insufficient defence against free radicals, according to the biochemical theory, result in excessive hydrogen peroxide (H2O2), which kills melanocytes. Some hypotheses suggest that the depigmentation process is caused by a combination of hereditary factors, defects in melanocyte structure and function, and a deficiency of melanocyte development factors [11].

Pathophysiology:

Melanocyte loss may occur gradually due to a number of causes, including immunological attack or cell degeneration and separation. According to the "convergence theory" or "integrated theory," two or more pathways may cooperate in vitiligo to cause melanocyte loss, which would ultimately result in the same clinical outcome [25]. The inflammatory pathophysiology of SV and NSV, however, appears to overlap, according to more recent data. Vascular dilatation and the immunological response follow the initial release of proinflammatory cytokines and neuropeptides brought on by internal or exterior injury, which appears to be a multistep process in both cases [26]. Known as the "neural hypothesis," some authors have proposed that the nerve system plays a role in the pathophysiology of vitiligo. This theory was predicated on SV's unilateral distribution pattern [27]. Moreover, there is little data to back up such a theory. Possible HLA connections in vitiligo were investigated because of the common correlation between vitiligo and autoimmune disorders. Several studies have linked HLA types A2, DR4, DR7, and Cw6 to vitiligo. The pathophysiology of vitiligo also suggests mutation [28]. Heritable biological characteristics that may make some people's melanocytes vulnerable to environmental triggers or other stressors, potentially leading to melnocyte death by necrosis, apoptosis, or pyroptosis, may be indicated by anecdotal reports of precipitating events by vitiligo patients [29]. Vitiligo can be caused by a variety of reasons, including the buildup of toxic substances, changes in the cellular environment, poor migration and/or proliferation of melanocytes, viral infections, neurological, autoimmune, and autocytotoxic factors, as well as psychological (patients' stress and personality traits) [30]. According to Al-Abadei et al., psychological stress may be the first stage in the pathophysiology of vitiligo since it raises levels of neuroendocrine hormones, impacts the immune system, and changes the amount of neuropeptides. [31] A thorough examination of the borders of active generalised vitiligo lesions has consistently revealed sparse infiltrates of cytotoxic T cells, and many individuals with the condition have serum autoantibodies and circulating autoreactive T cells that are directed against melanocytes and melanocyte components [29] Patients with vitiligo have been shown to have higher levels of soluble interleukin (IL)-2 receptor, IL-6, and IL-8, which further implies that T-cell activation may play a role in the pathophysiology of vitiligo [32],Because melanins are colloidal pigments with a strong affinity for metal ions, pigmented tissues involved in melanin formation were found to contain significant concentrations of specific metal ions, including copper, zinc, and iron. In conclusion, it is expected that the identification of the molecular processes underlying the pathogenesis of vitiligo will yield new therapeutic and preventative targets for upcoming strategies aimed at treating and preventing vitiligo and the autoimmune disorders that are linked to it [33]. Only the genes linked to autoimmune susceptibility—HLA, PTPN22, NALP1, and possibly CTLA4—have significant support at this time. Patients with vitiligo typically score higher on measures of anxiety, sadness, obsessive symptoms, adjustment difficulties, and hypochondria. Therefore, there might be a connection between stress and vitiligo growth

Epidemology:

Approximately 0.5 to 2% of adults and children worldwide are thought to have vitiligo, the most prevalent depigmenting skin condition [34]. But it appears that there are significant regional variations. In the Shaanxi Province of China, for instance, a research found a prevalence of 0.093% [35], but in other parts of India, rates reached 8.8% [36]. A comprehensive analysis of prevalence data from over 50 research conducted worldwide has shown that vitiligo prevalence varies from 0.06% to 2.28% [37]. " In a meta-analysis of 103 research, the pooled prevalence of vitiligo from 82 community- or population-based studies was 0.2%, and from 22 hospital-based studies, it was 1.8% [38]. While both men and women are equally impacted, women and girls tend to seek advice more frequently than men and boys, maybe as a result of the larger negative social impact [39]. In certain South Asian, Mexican, and American groups, the incidence has been observed to reach 4% . About 20% of vitiligo patients have at least one first-degree family who also has the condition, and the relative risk for first-degree relatives of vitiligo patients is seven to ten times higher [28]. The prevalence rates of vitiligo vary widely throughout the world, ranging from 0.004% to 2.28% [40]. The prevalence peaks in early adolescence for young women and between 45 and 60 for men [33].

CLASSIFICATION:

According to the assessment conducted by the Vitiligo Global Issues Consensus Conference in 2011 and 2012, there are four ways that Vitiligo might manifest clinically. mixed (SV+NSV), segmental, non-segmental, and unclassified. These subcategories vary in their aetiologies in addition to clinical symptoms, which include the onset of the first skin lesions, their location and extent, the presence of concomitant autoimmune illnesses, and the dermatosis's natural course [73]. The face (periorificial), hands (dorsal surfaces), nipples, axillae, umbilicus, sacrum, and inguinal/anogenital areas are among the areas that are frequently hyperpigmented and typically affected by vitiligo. It prefers the digits, flexor wrists, knees, and elbows on the extremities [41].

Segmental Vitiligo:

Segmental vitiligo is an acquired chronic pigmentation disease characterised by unilaterally distributed white patches that may resemble a dermatome entirely or in part. Hair bleaching is caused by its rapid impact on the follicular melanocyte reservoir [14]. One or more white, depigmented macules are dispersed on one side of the body in monosegmental vitiligo. It is SV's most prevalent form [42].

1. Focal Vitiligo:

The term "focal vitiligo" describes a small, isolated, depigmented lesion that has not changed over the course of one to two years and lacks a clear distribution pattern. It can develop into either SV or NSV [11].

2. Mucosal Vitiligo:

Oral and/or genital mucosae are usually affected by mucosal vitiligo. It might manifest as a separate ailment or as part of a larger case of vitiligo. A solitary case of mucosal vitiligo that persists for at least two years [11].

Non-Segmental Vitiligo:

The lesions are symmetrically dispersed across the body or bilaterally distributed in an acrofacial pattern. There are six other categories for this type:
NSV, or nonsegmental vitiligo, is the most prevalent kind of vitiligo, accounting for 80–90% of all instances. It is a long-term acquired pigmentation condition characterised by bilateral, usually symmetrical white spots that gradually get bigger and usually reflect a significant decrease in the number of melanocytes in the epidermis and some in the hair follicles that are still functional. NSV encompasses acrofacial, generalised, universal, mixed, localised, mucosal (when affecting many mucosal locations), and others [43].

1. Acrofacial Vitiligo:

Depigmented macules restricted to the face and/or distal extremities are a characteristic of acrofacial vitiligo. Depigmentation of the distal fingers and facial orifices is a characteristic. It might eventually spread to other bodily parts and be more appropriately categorised as universal or generalised [11].

2. Genralized Vitiligo:

Bilateral, frequently symmetrical, depigmented macules or patches that appear randomly across the body surface are the hallmark of generalised vitiligo. It frequently impacts regions that are prone to pressure, friction, and/or trauma. It could start in early adulthood or youth. Focal vitiligo, which may be a prelude to generalised vitiligo, is defined as a single macule or patch that lacks a segmental distribution and remains consistent over a period of two years [11].

3. Universal Vitiligo:

Complete or almost total skin depigmentation (affecting 80–90% of the body surface) is known as vitiligo universalis. [11]

Mixed Vitiligo:

When SV and NSV occur simultaneously, it is referred to as mixed vitiligo. A segmental distribution of depigmented areas is absent at birth and during the first year of life, and a wood lamp examination rules out nevus depigmentosus, among other clinical characteristics.  at least six months of delay between SV and NSV; SV affecting at least 20% of the dermatomal segment or exhibiting a distinct Blaschko linear distribution; and a difference between the response of SV (poor response) and NSV (good response) to standard narrow band ultraviolet B (NB-UVB) treatment. In SV patients, leukotrichia and halo nevi at onset may be risk factors for the development of MV [44]. Halo nevus (Sutton nevus) is the term used to describe the loss of pigmentation surrounding the pre-existing nevus that produces a halo. A high number of halo nevi indicates nested pigment-producing cell autoimmunity, which raises the risk of vitiligo [45]. Any part of the body that has strongly defined, depigmented, punctiform, 1- to 1.5-mm macules is referred to as "punctate vitiligo."[46].

Unclassified Vitiligo:

The two types of vitiligo that cannot be classified are mucosal, which occurs when just one mucosa is impacted, and focal, which occurs when isolated white macules without segmental dispersion [44]